SEC Company Response from Vincerx Pharma, Inc. (VINC) (CIK 0001796129) (VINC) — Mar 5, 2020
Vincerx Pharma, Inc. (VINC) (CIK 0001796129)
Date: March 5, 2020 · CIK: 0001796129 · Accession: 0001104659-20-029586
AI Filing Summary & Sentiment
File numbers found in text: 333-236466
Letter
VIA EDGAR Securities and Exchange Commission Division of Corporation Finance Attention: Ronald Alper Re: LifeSci Acquisition Corp. Registration Statement on Form S-1 (File No. 333-236466)
Dear Mr. Alper:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), the undersigned, for itself and the several underwriters, hereby joins in the request of LifeSci Acquisition Corp. that the effective date of the above-referenced Registration Statement be accelerated so as to permit it to become effective at 4:00 p.m., Washington D.C. time, on March 5, 2020, or as soon thereafter as practicable.
Pursuant to Rule 460 of the General Rules and Regulations under the Act, the undersigned advises that as of the date hereof, approximately 455 copies of the Preliminary Prospectus, dated March 3, 2020, have been distributed to prospective underwriters and dealers, institutional investors, retail investors and others.
The undersigned advises that it has complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
[Signature page follows]
Very truly yours,
Chardan Capital Markets, LLC,
Show Raw Text
CORRESP
1
filename1.htm
Chardan Capital Markets, LLC
17 State Street, Suite 1600
New York, New York 10004
March 5, 2020
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, D.C. 20549
Attention: Ronald Alper
Re:
LifeSci Acquisition Corp.
Registration Statement on
Form S-1 (File No. 333-236466)
Dear Mr. Alper:
Pursuant to Rule 461
of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), the undersigned, for
itself and the several underwriters, hereby joins in the request of LifeSci Acquisition Corp. that the effective date of the above-referenced
Registration Statement be accelerated so as to permit it to become effective at 4:00 p.m., Washington D.C. time, on March 5, 2020,
or as soon thereafter as practicable.
Pursuant to Rule
460 of the General Rules and Regulations under the Act, the undersigned advises that as of the date hereof, approximately 455
copies of the Preliminary Prospectus, dated March 3, 2020, have been distributed to prospective underwriters and dealers,
institutional investors, retail investors and others.
The undersigned advises
that it has complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934,
as amended.
[Signature page follows]
Very truly yours,
Chardan Capital Markets, LLC,
As Representative of the Underwriters
By:
/s/ George Kaufman
Name:
George Kaufman
Title:
Managing Director